Measurement of Perioperative Glomerular Filtration Rate
NCT03881332 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4
Last updated 2021-01-26
Summary
Our objective is to monitor glomerular filtration rate (GFR)during the perioperative phase of patients undergoing robotic surgery for rectum or large bowel cancers. We will use both a single injection and a continuous infusion of iohexol to measure kidney function for 72 hours after surgery.
Conditions
Sponsors & Collaborators
-
University Hospital of North Norway
lead OTHER
Principal Investigators
-
Lars Marius Ytrebo, PhD · University Hospital of North Norway
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-26
- Primary Completion
- 2021-01-22
- Completion
- 2021-01-22
Countries
- Norway
Study Locations
More Related Trials
-
Endoscopic Robot-Assisted Simple Enucleation Versus Standard Robot-Assisted Partial Nephrectomy in the Treatment of T1 Renal Cell Carcinoma
NCT03624673 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Fluorescent Lymphography-Guided Lymphadenectomy In Laparoscopic Proctectomy
NCT03854890 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery
NCT05739812 ·Status: UNKNOWN ·Phase: NA
-
Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma
NCT02645409 ·Status: COMPLETED ·Phase: NA
-
Preoperative Concurrent Chemotherapy and Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Rectal Cancer
NCT01340508 ·Status: UNKNOWN ·Phase: PHASE2
-
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC
NCT06665087 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Preoperative Chemoradiation Followed by Chemotherapy for Locally Advanced Rectal Cancer
NCT01952951 ·Status: UNKNOWN ·Phase: PHASE2
-
Preoperative Chemoradiation With Capecitabine and Cetuximab
NCT00297128 ·Status: COMPLETED ·Phase: PHASE2
-
Preoperative CRT With Capecitabine ± Temozolomide in Patients With LARC
NCT03156036 ·Status: COMPLETED ·Phase: PHASE2
-
Fluorescence Molecular Endoscopy and Molecular Fluorescence-guided Surgery in Locally Advanced Rectal Cancer
NCT04638036 ·Status: COMPLETED ·Phase: PHASE1
-
PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During Surgery
NCT00004891 ·Status: COMPLETED ·Phase: NA
-
Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer
NCT02151019 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer
NCT00613080 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Preoperative Radiation Therapy and Capecitabine in Locally Advanced Rectal Cancer
NCT00122291 ·Status: UNKNOWN ·Phase: PHASE2
-
Prospective Trial for the Evaluation of Radiogenomics in Advanced Rectal Cancer
NCT04287400 ·Status: RECRUITING
-
Efficacy Study of Robotic Surgery for Rectal Cancer
NCT01591798 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Study of Radical Right Hemicolectomy Versus Radical Right Hemicolectomy Combined with Indocyanine Green Fluorescence Imaging Lymphatic Tracer Dissection for the Treatment of Right Colon Cancer
NCT06485609 ·Status: RECRUITING ·Phase: NA
-
Sphincter-preserving Surgery After Preoperative Treatment of Ultra-low Rectal Carcinoma
NCT00979680 ·Status: COMPLETED ·Phase: PHASE3
-
Computer Navigation-assisted Surgery for Locally Advanced and Recurrent Rectal Cancer
NCT04512937 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Sentinel Lymph Node Biopsy in Rectal Cancer
NCT05830890 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer
NCT07090031 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Genotype-directed Neoadjuvant Chemoradiation for Rectal Carcinoma
NCT00682786 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolomics to Predict Treatment Response and Toxicities in Rectal Cancer
NCT06831669 ·Status: RECRUITING
-
A Prospective Study Utilizing Circulating Cell Free DNA (cfDNA) Use in the Detection of RAS Mutations in Patients With Advanced Colorectal Cancer.
NCT04775862 ·Status: UNKNOWN ·Phase: PHASE2
-
A Trial of Pre-Operative Chemoradiotherapy Using Capecitabine, Radiation & Cetuximab, in Rectal Cancer
NCT01310985 ·Status: COMPLETED